Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Reports Findings in Cell, Nature

Premium

Rosetta Inpharmatics reported findings in Cell and Nature Genetics that highlight how gene expression analysis technologies can be used to decipher the gene function as well as the molecular mechanisms of disease.

The study reported in Nature demonstrated how Rosetta’s FlexJet Arrray technology could be used to understand the basis of molecular events common in cancer.

In the Cell study, Rosetta’s scientists generated a database of gene expression profiles with a variety of phenotypes and employed chemical treatments to systematically analyze the profiles.

Filed under

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.